Opioid Use Disorder
Opioid Use Disorder
Explore linked clinical trials. Standard reference: MESH:M000677411219 results · Page 1 of 9
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Supporting Treatment for Opioids and Recovery Capital (STORC) - R61 Phase | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-10-09 | NCT07787039 | |
| Cannabis and Opioid Use Disorder, Study 2 | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, cannabis dependence, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 1 | 2026-10-09 | NCT07661446 | |
| Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 4 | 2026-10-09 | NCT07176351 | |
| The Effect of Light Intervention on Recovery in Individuals With Opioid Use Disorder (OUD) | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-10-09 | NCT06832007 | |
| Towards Testing the Effectiveness of Recovery Community Centers (RCCs) | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Not applicable | 2026-10-08 | NCT07010978 | |
| Measurement Based Care in Opioid Treatment Programs | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Enrolling by invitation | Not applicable | 2026-10-08 | NCT06965010 | |
| Clinician Practice Companion to Address Youth Substance Use | Chemically-Induced Disorders, Drug Misuse, Drug Overdose, Narcotic-Related Disorders, Opioid Use Disorder, Prescription Drug Misuse, Substance Use, cannabis dependence, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Not applicable | 2026-10-07 | NCT07725289 | |
| A Study of Brenipatide in Participants With Opioid Use Disorder | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 2 | 2026-10-07 | NCT07420283 | |
| Machine-Learning Prediction and Reducing Overdoses With EHR Nudges | Chemically-Induced Disorders, Drug Misuse, Drug Overdose, Narcotic-Related Disorders, Opiate Overdose, Opioid Use Disorder, Prescription Drug Misuse, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Not applicable | 2026-10-06 | NCT06806163 | |
| Safety, Tolerability, and Pharmacokinetics of MCAM in Healthy Adult Participants | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Early phase 1 | 2026-10-05 | NCT07602335 | |
| Cannabidiol in Opioid Use Disorder and Chronic Pain | Chemically-Induced Disorders, Chronic Pain, Narcotic-Related Disorders, Neurologic Manifestations, Opioid Use Disorder, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Early phase 1 | 2026-10-05 | NCT04587791 | |
| Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 1 | 2026-10-02 | NCT07800520 | |
| A Bundled Intervention to End Opioid Overdoses | Chemically-Induced Disorders, Disease Attributes, Drug Misuse, Drug Overdose, Emergencies, Narcotic-Related Disorders, Opiate Overdose, Opioid Use Disorder, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Prescription Drug Misuse, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 4 | 2026-10-02 | NCT07485335 | |
| Mobile Platform for Optimizing Wellness and Engagement in Recovery | Alcohol Use Disorder, Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, alcohol-related disorders, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Not applicable | 2026-10-02 | NCT07178990 | |
| Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses | Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Narcotic-Related Disorders, Neoplasms by Histologic Type, Opioid Use Disorder, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-10-01 | NCT07631598 | |
| Real-World Evaluation of Compl-AI for Predicting Early Medication Dropout in Opioid Use Disorder Treatment | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Not stated | 2026-10-01 | NCT07456930 | |
| Measurement-Based Care to Support Buprenorphine-Naloxone Treatment in Outpatient Addiction Clinics | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Not applicable | 2026-09-30 | NCT07839182 | |
| iSTEP-N 101b: Pharmacokinetics and Safety Study of Low- and High-Dose Naltrexone Implants vs Monthly Vivitrol in Healthy Volunteers | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 1 | 2026-09-30 | NCT07064564 | |
| Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-09-30 | NCT06732596 | |
| Evaluation of Clinical Decision Support in Opioid Tapering | Chemically-Induced Disorders, Drug Misuse, Drug Overdose, Narcotic-Related Disorders, Opiate Overdose, Opioid Use Disorder, Prescription Drug Misuse, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Not stated | 2026-09-30 | NCT06527079 | |
| Behavioral Optimization for Overcoming Suboptimal Treatment Retention (BUP-BOOSTeR) | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Not applicable | 2026-09-29 | NCT07607743 | |
| TRTME: Improving Outpatient Initiation of Medication for Opioid Use Disorder Following Hospitalization | Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Narcotic-Related Disorders, Neoplasms by Histologic Type, Opioid Use Disorder, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, opiate dependence, psychiatric disorder, substance-related disorder | Enrolling by invitation | Not applicable | 2026-09-28 | NCT07780097 | |
| Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not stated | 2026-09-28 | NCT06487533 | |
| Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-09-28 | NCT06157840 | |
| Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 2 | 2026-09-28 | NCT05382091 |